Interaction of the EGFR inhibitors gefitinib, vandetanib, pelitinib and neratinib with the ABCG2 multidrug transporter: Implications for the emergence and reversal of cancer drug resistance

The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype

Sheng Zhou, John D. Schuetz, Kevin D. Bunting et al. · Nature Medicine · 2001 · 2.3K citations

Life Sciences, Cell Biology, Molecular Biology +7

A distinct “side population” of cells with high drug efflux capacity in human tumor cells

Charlotte Hirschmann-Jax, Angela E. Foster, Gerald Wulf et al. · Proceedings of the National Academy of Sciences · 2004 · 1.3K citations

Medicine, Cell Biology, Oncology +17

Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib

Eunice L. Kwak, Raffaella Sordella, Daphne W. Bell et al. · Proceedings of the National Academy of Sciences · 2005 · 952 citations

Medicine, Medicinal Chemistry, Pharmacology +13

Side Population in Human Lung Cancer Cell Lines and Tumors Is Enriched with Stem-like Cancer Cells

Maria Ho, Alvin V. Ng, Stephen Lam et al. · Cancer Research · 2007 · 947 citations

Medicine, Cell Biology, Oncology +15

PTEN/PI3K/Akt Pathway Regulates the Side Population Phenotype and ABCG2 Activity in Glioma Tumor Stem-like Cells

Anne-Marie Bleau, Dolores Hambardzumyan, Tatsuya Ozawa et al. · Cell stem cell · 2009 · 801 citations · Full text

Medicine, Cancer Biology, Oncology +17